Clinical Outcomes After Laser Hemorrhoidoplasty (LHP)

Clinical Outcomes, Pain Scores, and Patient Satisfaction in Patients Undergoing Laser Hemorrhoidoplasty: A Prospective Observational Study

This single-center prospective observational study aims to evaluate clinical outcomes, postoperative pain scores, complications, and patient satisfaction in adults undergoing laser hemorrhoidoplasty for symptomatic internal hemorrhoidal disease. Additional objectives are to assess the relationship between hemorrhoid stage, dominant presenting symptoms, operative technical details, and postoperative outcomes. No study-specific intervention beyond routine clinical care and follow-up will be performed.

Study Overview

• Status: Not yet recruiting
• Conditions: Hemorrhoidal Disease; Internal Hemorrhoids
• Intervention / Treatment: Procedure: Laser Hemorrhoidoplasty

Detailed Description

Hemorrhoidal disease is a common benign anorectal condition that can significantly impair quality of life. Conventional excisional techniques may be associated with postoperative pain, bleeding, prolonged recovery, and lower patient satisfaction. Laser hemorrhoidoplasty is a minimally invasive technique based on coagulation and shrinkage of hemorrhoidal tissue without excision. This prospective observational study will be conducted at the General Surgery Clinic of Sanliurfa Education and Research Hospital. Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty will be enrolled. Preoperative symptoms, hemorrhoid stage, and physical examination findings will be recorded. Intraoperative data will include laser wavelength, total delivered energy, number of hemorrhoidal packages treated, and any additional surgical procedures. Postoperative pain will be assessed at predefined time points using the Visual Analog Scale. Analgesic requirement and duration, length of hospital stay, time to return to daily activities, early complications within 30 days, late complications, symptom status, and recurrence at 6 months will be documented. The study is designed to clarify the clinical role of laser hemorrhoidoplasty and help define appropriate patient selection criteria.

• Study Type: Observational
• Enrollment (Estimated): 60

Contacts and Locations

• Study Contact: Name: Vedat Kaplan, MD; Phone Number: +905459045165; Email: vedat_kaplan_@hotmail.com

Study Locations

• Turkey (Türkiye)
  • Şanlıurfa
    • Sanliurfa, Şanlıurfa, Turkey (Türkiye)
      • Sanliurfa Education and Research Hospital
      • Contact: Vedat Kaplan, MD; Phone Number: +905459045165; Email: vedat_kaplan_@hotmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Adult patients with symptomatic internal hemorrhoidal disease who are scheduled to undergo laser hemorrhoidoplasty at the General Surgery Clinic of Sanliurfa Education and Research Hospital.

Description

Inclusion Criteria:

• Age 18 years or older
• Symptomatic internal hemorrhoidal disease
• Scheduled to undergo laser hemorrhoidoplasty
• Willingness to participate and provision of informed consent

Exclusion Criteria:

• Grade IV hemorrhoidal disease
• Acute thrombosed hemorrhoids
• Additional anorectal pathology such as anal fissure, fistula, or perianal abscess
• History of inflammatory bowel disease or colorectal malignancy
• Previous major anal surgery'

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients undergoing laser hemorrhoidoplasty; Adults with symptomatic internal hemorrhoidal disease undergoing laser hemorrhoidoplasty.	Procedure: Laser Hemorrhoidoplasty; Laser-based minimally invasive treatment of internal hemorrhoidal disease performed as part of routine clinical care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Postoperative pain score	Postoperative pain assessed using a 0 to 10 Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst imaginable pain; higher scores indicate worse pain.	At 6 hours, 24 hours, and 1 week after surgery

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Duration of postoperative analgesic use	Duration of postoperative analgesic use, measured in days.	From the day of surgery through 30 days after surgery
Length of hospital stay	Postoperative hospital stay, measured in days from the date of surgery to the date of discharge.	From the day of surgery to hospital discharge, up to 7 days
Incidence of predefined early postoperative complications	Number and proportion of patients who develop any predefined early postoperative complication within 30 days after laser hemorrhoidoplasty. Predefined complications include postoperative bleeding, urinary retention, anal thrombosis, infection, severe pain, and anal stenosis. Patients without any of these events will be classified as having no complication.	Within 30 days after surgery
Time to return to daily activities	Time required to return to usual daily activities, measured in days.	Up to 30 days after surgery
Patient satisfaction	Patient-reported satisfaction after laser hemorrhoidoplasty.	Up to 3 months after surgery

Collaborators and Investigators

• Sponsor: Sanliurfa Education and Research Hospital
• Investigators: Principal Investigator: Vedat Kaplan, Sanliurfa Education and Research Hospital

Study record dates

Study Major Dates

• Study Start (Estimated): April 1, 2026
• Primary Completion (Estimated): January 1, 2027
• Study Completion (Estimated): April 1, 2027

Study Registration Dates

• First Submitted: March 24, 2026
• First Submitted That Met QC Criteria: April 2, 2026
• First Posted (Actual): April 9, 2026

Study Record Updates

• Last Update Posted (Actual): April 9, 2026
• Last Update Submitted That Met QC Criteria: April 2, 2026
• Last Verified: April 1, 2026

More Information

Terms related to this study

• Keywords: Patient satisfaction; Hemorrhoidal disease; Visual Analog Scale; Laser hemorrhoidoplasty
• Additional Relevant MeSH Terms: Behavior; Treatment Adherence and Compliance; Health Behavior; Patient Satisfaction
• Other Study ID Numbers: SEAH-LHP

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Individual participant data will not be shared because this is a single-center study involving sensitive patient-level clinical data, and there is no pre-specified institutional mechanism for external data sharing. Only aggregated, de-identified study results will be reported.

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No